BOSTON SCIENTIFIC CORP (BSX)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$50.47
-1.87%
Investingg Score
59.9 / 100
Hold
Business overview
- Operates in the Surgical & Medical Instruments & Apparatus industry.
- Reports a gross margin of 69% and an operating margin of 18%.
These margins reflect solid core profitability within its medical device sector, though overall financial quality scores moderately at 52.
Financial health
- Free cash flow margin stands at 18.2%.
- The balance sheet pillar receives a score of 46.
These figures indicate healthy cash generation despite a lower balance sheet safety score that introduces some financial uncertainty.
- Gross Margin
- 69.0%
- Operating Margin
- 18.0%
- Current Ratio
- 1.6x
- Debt / Equity
- Data unavailable
- Free Cash Flow (TTM)
- $3.7B
- Interest Coverage
- 10x
Valuation
- Price-to-earnings and EV-to-EBITDA ratios are unavailable (null).
- Price-to-sales ratio is listed as 0.
Data limitations restrict a complete valuation assessment, though the assigned valuation score sits at 58.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- Price / Sales
- 0.0x
- EV / EBITDA
- Data unavailable
- FCF Yield
- Data unavailable
Key risks
- Data unavailable for comprehensive valuation metrics like P/E and EV-to-EBITDA.
- A lower balance sheet score of 46 introduces underlying financial uncertainty.
- The 200-day simple moving average comparison shows a significant 28.1% discount, highlighting potential long-term trend risks.
Market cap $0 · data as of 2026-08-18
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze BSX with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.